ClinVar Miner

Submissions for variant NM_000329.3(RPE65):c.1430A>G (p.Asp477Gly)

dbSNP: rs1571158279
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Farrar Lab, Smurfit Institute of Genetics, Trinity College Dublin RCV001034696 SCV001021978 pathogenic RPE65-related disorder 2019-12-10 criteria provided, single submitter clinical testing The Asp477Gly variant has been previously reported in several publications (Bowne 2011, PMID: 21654732; Hull 2016, PMID: 27307694). Functional analysis in animal models of the variant has also displayed a similar pathology (Shin 2017, PMID: 28041994). This missense mutation appears to result in aberrant RNA splicing (Li 2019, PMID: 30628748). The phenotype is an unusual retinitis pigmentosa, often presenting as a phenocopy of choroideremia. The inheritance pattern is autosomal dominant with a variable age of onset. The variant is absent from large population databases (gnomAD). In the Irish population there are currently 23 individuals confirmed affected with this genotype from 7 different pedigrees. Based on population, cosegregation and functional data, we interpret this variant as pathogenic.
Invitae RCV001068036 SCV001233124 pathogenic Leber congenital amaurosis 2; Retinitis pigmentosa 20 2023-11-04 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 477 of the RPE65 protein (p.Asp477Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal dominant retinal dystrophy with choroidal involvement (PMID: 21654732, 27307694, 29947567). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 750796). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RPE65 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects RPE65 function (PMID: 21654732, 28041994, 29659842, 30628748). For these reasons, this variant has been classified as Pathogenic.
Blueprint Genetics RCV001074701 SCV001240294 pathogenic Retinal dystrophy 2019-04-03 criteria provided, single submitter clinical testing
Ocular Genomics Institute, Massachusetts Eye and Ear RCV001376263 SCV001573342 pathogenic Retinitis pigmentosa 20 2021-04-08 criteria provided, single submitter research The RPE65 c.1430A>G variant was identified in an individual with retinitis pigmentosa with a presumed dominant inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PS3, PM2, PP1-S. Based on this evidence we have classified this variant as Pathogenic.
Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes RCV002279647 SCV002564458 pathogenic Neurodevelopmental disorder 2021-12-16 criteria provided, single submitter clinical testing
GeneDx RCV003117646 SCV003798948 likely pathogenic not provided 2023-02-02 criteria provided, single submitter clinical testing Reported to co-segregate with a late-onset form of autosomal dominant RP (adRP) with choroidal involvement (Kiang et al., 2020; Jauregui et al., 2018; Doucette et al., 2021; Browne et al., 2011); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Published functional studies suggest this variant has a dominant negative effect and may cause aberrant splicing, however additional studies are needed to validate the functional effect of this variant in vivo (Li et al., 2019; Wu et al., 2022); This variant is associated with the following publications: (PMID: 27307694, 28041994, 32581362, 33261050, 32426524, 33512609, 30628748, 33776059, 29659842, 21654732, 29947567, 32014860, 35271391)
OMIM RCV000927801 SCV001073396 pathogenic Retinitis pigmentosa 87 with choroidal involvement 2020-04-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.